These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9295130)

  • 41. Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.
    Strobel I; Krumbholz M; Menke A; Hoffmann E; Dunbar PR; Bender A; Hobom G; Steinkasserer A; Schuler G; Grassmann R
    Hum Gene Ther; 2000 Nov; 11(16):2207-18. PubMed ID: 11084678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.
    Ribas A; Butterfield LH; Hu B; Dissette VB; Meng WS; Koh A; Andrews KJ; Lee M; Amar SN; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Apr; 60(8):2218-24. PubMed ID: 10786687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
    Sas S; Chan T; Sami A; El-Gayed A; Xiang J
    Cancer Gene Ther; 2008 Oct; 15(10):655-66. PubMed ID: 18421311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
    Diao J; Smythe JA; Smyth C; Rowe PB; Alexander IE
    Gene Ther; 1999 May; 6(5):845-53. PubMed ID: 10505110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
    Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.
    Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J
    Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
    Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo.
    Peng W; Zhao G; Ma Y; Yu H; Wang X
    Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.
    Kim JW; Kane JR; Panek WK; Young JS; Rashidi A; Yu D; Kanojia D; Hasan T; Miska J; Gómez-Lim MA; Ulasov IV; Balyasnikova IV; Ahmed AU; Wainwright DA; Lesniak MS
    Neurotherapeutics; 2018 Oct; 15(4):1127-1138. PubMed ID: 30027430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
    Miller PW; Sharma S; Stolina M; Butterfield LH; Luo J; Lin Y; Dohadwala M; Batra RK; Wu L; Economou JS; Dubinett SM
    Hum Gene Ther; 2000 Jan; 11(1):53-65. PubMed ID: 10646639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In vivo migration and survival of donor-derived dendritic cell progenitors genetically modified using an adenoviral vector encoding cDNA for TGF beta 1].
    Zhong C; Li WZ; Lü L
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):174-7. PubMed ID: 11601033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
    Kikuchi T; Moore MA; Crystal RG
    Blood; 2000 Jul; 96(1):91-9. PubMed ID: 10891436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta.
    Lee WC; Zhong C; Qian S; Wan Y; Gauldie J; Mi Z; Robbins PD; Thomson AW; Lu L
    Transplantation; 1998 Dec; 66(12):1810-7. PubMed ID: 9884280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer.
    Akbulut H; Tang Y; Akbulut KG; Maynard J; Zhang L; Deisseroth A
    Mol Cancer Ther; 2006 Aug; 5(8):1975-85. PubMed ID: 16928818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
    Reeves ME; Royal RE; Lam JS; Rosenberg SA; Hwu P
    Cancer Res; 1996 Dec; 56(24):5672-7. PubMed ID: 8971174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.
    Hensley SE; Giles-Davis W; McCoy KC; Weninger W; Ertl HC
    J Immunol; 2005 Nov; 175(9):6032-41. PubMed ID: 16237098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin.
    Zhang W; He L; Yuan Z; Xie Z; Wang J; Hamada H; Cao X
    Hum Gene Ther; 1999 May; 10(7):1151-61. PubMed ID: 10340547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W; He L; Cao X
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.